SCIENTIFIC BACKGROUND

CFTR

Category:

Scientific Background

Cystic fibrosis (CF) is one of the most common autosomal recessive inherited diseases in the Caucasian population (frequency 1:2500, frequency of carriers 1:25). Affected persons suffer from chronic pulmonary symptoms (frequent bronchopulmonary infections, persistent bronchiectasis) and gastrointestinal symptoms (pancreatic insufficiency, pancreatitis, meconium ileus (pre- or neonatal)), and male infertility is seen. It is caused by pathogenic changes in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which leads to the functional disruption of a chloride channel in the apical membrane of glandular epithelial cells and thus to a change in the salt content of sweat and other body secretions.

 

The most frequently detected pathogenic alteration of the CFTR gene in many populations is the variant p.Phe-508del (F508del). There are >2000 other pathogenic changes in the CFTR gene currently described that are significantly less frequent. The development of the disease depends on the type and severity of the CFTR variants. In addition to the classical, early manifesting and multisystemic cystic fibrosis, milder, monosymptomatic forms have also been described and are grouped under the so-called CFTR-RDs (related disorder). These include disseminated bronchiectasis, atypical chronic rhinosinusitis, chronic pancreatitis or CBAVD (congenital bilateral aplasia of the vas deferens).

 

Early diagnosis is of great importance with regard to optimal care of those affected. Molecular genetic diagnostics to confirm the suspected clinical diagnosis and determine the CFTR genotype can have a decisive influence on the later choice of therapy. CF diagnostics have also been part of newborn screening since 2016.

 

References

Goetz et Ren 2019, Pediatr Ann 48:e154 / Wiencek et Lo 2018, Clin Chem 64:898 / Sosnay et al. 2017, J Pediatr 181S:S52 / Farrell et al. 2017, J Pediatr 181S:S4 / Dequeker et al. 2009, Eur J Hum Genet 17:51 / Castellani et al. 2008, J Cyst Fibros 7:179 / Ogino et al. 2004 J Med Genet 41:e70 / Steiner et al. 2004, Hum Mutat 24:120 / Bobadilla et al. 2002, Hum Mutat 19:575 / Claustres et al. 2000, Hum Mutat 16:143

GENES

CFTR

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more